You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.1 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 8.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -942.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | n/a | -2.30 | -7.79p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-03-31 | n/a | -3.22 | -6.29p | -3.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-03-31 | n/a | -3.64 | -4.19p | -5.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | n/a | -3.03 | -3.28p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | n/a | -3.12 | -2.74p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | 0.00 | -3.00 | -2.40p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-03-31 | 0.00 | -3.30 | -2.10p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Evgen Pharma upbeat on latest news from SFX-01 studies Sharecast News | 23 Sep |
|---|---|
| Evgen Pharma completes patient study visits in 'SAS' phase 2 trial Sharecast News | 28 Aug |
| Evgen Pharma gets further protection for 'SFX-01' in Europe Sharecast News | 07 Aug |
| ESMO presentation of Phase II STEM clinical data | 30-Sep-19 07:05 |
|---|---|
| Update on extended-use phase of STEM trial | 23-Sep-19 07:02 |
| Agreement for supply of SFX-01 for autism trial | 05-Sep-19 07:02 |
| Update on SAS study | 28-Aug-19 07:02 |
| Grant of further European patent | 07-Aug-19 07:00 |